-
781
-
782
Mechanistic PKPD modeling to describe cytokine release associated with CD3 T-cell engager therapies
Published 2025-01-01Subjects: “…cancer immunotherapy (CIT)…”
Get full text
Article -
783
Therapy of genomic unstable solid tumours (WHO grade 3/4)in clinical stage III/IV using individualised neoantigen tumour peptides-INP trial (individualised neoantigen tumour peptides immunotherapy): study protocol for an open-label, non-randomised, prospective, single-arm trial
Published 2022-06-01Get full text
Article -
784
Effectiveness and safety of pembrolizumab, nivolumab, and atezolizumab as adjuvant therapy for high-risk muscle-invasive urothelial carcinoma: an indirect comparison
Published 2025-01-01Subjects: “…adjuvant immunotherapy…”
Get full text
Article -
785
-
786
Acute kidney injury in patients treated with immune checkpoint inhibitors: a single-center retrospective study
Published 2024-12-01Subjects: Get full text
Article -
787
-
788
Paradoxical control of multifocal mammary oncogenesis by radiation therapy
Published 2025-12-01Subjects: Get full text
Article -
789
-
790
Oncological principles in the management of ocular surface squamous neoplasia - A Review
Published 2025-02-01Subjects: Get full text
Article -
791
Cancer-associated fibroblasts promote pro-tumor functions of neutrophils in pancreatic cancer via IL-8: potential suppression by pirfenidone
Published 2025-02-01“…Cancer Immunology, Immunotherapy…”
Get full text
Article -
792
Spontaneous high clonal expansion of Wilms’ tumor gene 1-specific cytotoxic T-lymphocytes in patients with Wilms’ tumor gene 1-expressing solid tumor
Published 2024-11-01“…Cancer Immunology, Immunotherapy…”
Get full text
Article -
793
Differential T cell accumulation within intracranial and subcutaneous melanomas is associated with differences in intratumoral myeloid cells
Published 2024-11-01“…Cancer Immunology, Immunotherapy…”
Get full text
Article -
794
Early detection of myocarditis caused by immune checkpoint inhibitor therapy with nivolumab and ipilimumab for advanced recurrent renal cell carcinoma
Published 2025-02-01“…Cancer Immunology, Immunotherapy…”
Get full text
Article -
795
Intratumoural CD8+ CXCR5+ follicular cytotoxic T cells have prognostic value and are associated with CD19+ CD38+ B cells and tertiary lymphoid structures in colorectal cancer
Published 2024-12-01“…Cancer Immunology, Immunotherapy…”
Get full text
Article -
796
Normalization of tumor vasculature by imiquimod: proposal for a new anticancer therapeutic indication for a TLR7 agonist
Published 2025-02-01“…Cancer Immunology, Immunotherapy…”
Get full text
Article -
797
Selective JAK2 pathway inhibition enhances anti-leukemic functionality in CD19 CAR-T cells
Published 2025-02-01“…Cancer Immunology, Immunotherapy…”
Get full text
Article -
798
Q11, a CYP2E1 inhibitor, exerts anti-hepatocellular carcinoma effect by inhibiting M2 macrophage polarization
Published 2024-12-01“…Cancer Immunology, Immunotherapy…”
Get full text
Article -
799
Loop33 × 123 CAR-T targeting CD33 and CD123 against immune escape in acute myeloid leukemia
Published 2024-11-01“…Cancer Immunology, Immunotherapy…”
Get full text
Article -
800
The profiles of immunosuppressive microenvironment in the Lauren intestinal-type gastric adenocarcinoma
Published 2025-02-01“…Cancer Immunology, Immunotherapy…”
Get full text
Article